fda tirzepatide compound approval Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro FDA Ban on Compounded GLP-1

Tell your healthcare professional if you experience new or worsening depression, suicidal thoughts, or any unusual changes in mood or behavior, the FDA wrote

LIKE WHAT YOURE READING

The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)

Case Study 1: The Hidden Autoimmune Disease A 32-year-old patient noticed white stringy mucus in stool and bloating consistently for several months

Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic condition characterized by bladder pressure, bladder pain, and sometimes pelvic pain

Wegovy (semaglutide) The STEP UP trial followed 1,407 adults with obesity over 72 weeks